Cargando…
Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design
Neuraminidase (NA) inhibitors are the dominant antiviral drugs for treating influenza in the clinic. Increasing prevalence of drug resistance makes the discovery of new NA inhibitors a high priority. Thirty-one triterpenoids from the medicinal mushroom Ganoderma lingzhi were analyzed in an in vitro...
Autores principales: | Zhu, Qinchang, Bang, Tran Hai, Ohnuki, Koichiro, Sawai, Takashi, Sawai, Ken, Shimizu, Kuniyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549708/ https://www.ncbi.nlm.nih.gov/pubmed/26307417 http://dx.doi.org/10.1038/srep13194 |
Ejemplares similares
-
Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012) -
Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019) -
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017) -
Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011) -
Inhibiting neuraminidase can make the difference
por: Rappuoli, Rino, et al.
Publicado: (2019)